BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2001
View Archived Issues
SciClone's Zadaxin receives expanded approval in Mexico
Read More
Gene synthesis patent licensed by Blue Heron
Read More
S-34211: an orally available direct thrombin inhibitor with potent antithrombotic properties
Read More
Safe and effective heparin/LMWH antidote developed at Commonwealth Biotechnologies
Read More
P2T antagonist AR-C69931 acts synergistically with PGE1 to inhibit Ca2+ mobilization in platelets
Read More
ML-3000 inhibits PMN/platelet interactions in vitro
Read More
Factor VIII retroviral construct safe and potentially effective in hemophilia A patients
Read More
Blood outgrowth endothelial cell-based gene therapy for hemophilia tested in mice
Read More
Human factor VIII-expressing gutless adenovirus vector for hemophilia A
Read More
Genencor and Epimmune to codevelop vaccines for three oncogenic viruses
Read More
Company Profile: Diabetogen
Read More
Beneficial effects reported for T-588 in animal model of ALS
Read More
NDS filed for d-methylphenidate in Canada for ADD and ADHD
Read More
Immtech International achieves several milestones during fourth quarter
Read More
TheraCIM h-R3 enters phase I/II for additional indication
Read More
Selective iNOS inhibitor Ono-1714 ameliorates pancreatitis
Read More
Peripheral-type cannabinoid receptor ligand shows efficacy in acute pancreatitis
Read More
Oral thrombin inhibitors designed at Knoll (Abbott) inhibit both free and fibrin-bound thrombin
Read More
OrthoLogic extends Chrysalin license
Read More
Combined PDE3/PDE4 inhibitor therapy for obesity
Read More
Bezafibrate: the first oral agent with antiinflammatory and antiviral activity in HCV
Read More
Allergan claims new cyclopentane derivatives for glaucoma management
Read More
CRF antagonists and their therapeutic application reported by Pfizer
Read More
Joint research at Japanese labs leads to new series of sphingomyelinase inhibitors
Read More
Pharmacological profile of new NK1 receptor antagonist from Roche
Read More
Potent GABA-A agonists identified by Merck in a series of pyrazolotriazines
Read More
GABA-A receptor ligands useful for anxiety, convulsions described by Merck
Read More